"On the flip side, MannKind Corporation (NASDAQ:MNKD) declined the most among biotech stocks after The Motley Fool pointed out concerns remaining, based on its presentation at the 31st Annual J.P. Morgan Healthcare Conference and the upcoming clinical data."
http://www.gaininggreen.com/news-highlights-movers-shakers-in-the-biotech-industry/122563/